Particular GFRN members can upregulate anti-apoptotic proteins such as BCL-2, BCL-XL, and MCL-1 and downregulate pro-apoptotic proteins such as BAD, BAX, and BIM, all of which contribute to apoptosis evasion and resistance to cancer treatments in patients [22–29]. The gene discussed is BAD; the disease is cancer.